Clinical Laserthermia Systems AB (publ) Capital Reinvestment Ratio

Latest as of December 2017: 1.75x

Clinical Laserthermia Systems AB (publ) capital reinvestment ratio. Clinical Laserthermia Systems AB (publ) (CLS-B) has a Capital Reinvestment Ratio of 1.75x as of December 2017, meaning it reinvests 2% of its operating cash flow (Skr372.00K) in capital expenditures (Skr652.55K). Check CLS-B cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

1.75x

Capex / Operating Cash Flow

Operating Cash Flow

Skr372.00K

SEK

Capital Expenditures

Skr652.55K

SEK

Data as of

Dec 2017

Most recent filing

Clinical Laserthermia Systems AB (publ) Capital Reinvestment Ratio by Year (None–None)

Clinical Laserthermia Systems AB (publ) capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see Clinical Laserthermia Systems AB (publ) (CLS-B) cash conversion ratio.

Year	Reinvestment Ratio	Operating CF (SEK)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow